3- ((2- nitro- 4- azidophenyl)- 2- aminoethyldithio)- N- succinimidyl propionate
structure given in first source
Also Known As:
N-SNAP; NAPAETSP; 2,5-Pyrrolidinedione, 1-(3-((2-((4-azido-2-nitrophenyl)amino)ethyl)dithio)-1-oxopropoxy)-
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
| 1. | Alzheimer Disease (Alzheimer's Disease)
01/01/2016
- " Individuals were categorised as A(-)N(-), A(+)N(-), A(+)N(+), or suspected non-Alzheimer's disease pathophysiology (A(-)N(+), SNAP). " 01/01/2020
- " Specifically, we identified the normal control (NC; subjects with normal biomarkers, A-T-N-), SNAP (subjects with normal amyloid but abnormal tau, A-T+), and predementia Alzheimer's disease (AD; subjects with abnormal amyloid and tau, A+T+). "
|
|
Related Drugs and Biologics